Insights On Enterprise Solutions

  1. Thermo Fisher Scientific Capabilities Update July 2026: Fill/Finish 8/6/2026

    When working with high-value biologics, ADCs, and personalized medicines, material utilization decisions made before GMP manufacturing can make or break your program yield. Learn how early choices matter.

  2. Why Analytical Characterization Now Drives Biosimilar Development 8/3/2026

    Updated FDA guidance establishes that biosimilar sponsors should generate comprehensive, comparative physicochemical and functional data early to establish more effective development strategies.

  3. What Capacity And Cost Won't Tell You About A Fill-Finish CDMO 8/3/2026

    Evaluating fill-finish CDMOs beyond cost and capacity ensures long-term success. Strategic focus on technical depth, scalability, and modern compliance reduces risk.

  4. Quality From The Start: A Practical Approach To Regulatory Compliance And Market Success 7/31/2026

    Integrating quality early in biopharma development reduces risk, speeds commercialization, and ensures compliance through inspection readiness and ongoing analytical oversight.

  5. What Does a Friendly CDMO Expert Look Like? 7/31/2026

    Transparent, collaborative outsourcing reduces supply chain risk and protects IP. Open communication and proactive problem-solving keep development on track and speed commercialization.

  6. Webinar Highlights: The Missing Layer Holding Lab Operations Back 7/30/2026

    Scientific work depends on more than data alone. Learn how connected process context, decision logic, deviation tracking, and workflow orchestration can help teams improve traceability and execution.

  7. Step Inside Our Sterile Injectable Campus 7/30/2026

    Advanced automated filling lines and integrated development services streamline production, ensuring process integrity and faster timelines from early formulation to commercial supply.

  8. Creating Technical Debt When Experimenting With 3D Printed Parts 7/29/2026

    Companies need mature validation paradigms to recognize if and when it's time to transition from a prototype 3D printed part to a sustainable version, likely through a vendor-validated part.

  9. Cooperating With Suppliers To Produce 3D-Printed Prototypes 7/29/2026

    Single-use components made with injection molding will almost always outperform compared to those made on a 3D printer.

  10. Why US Pharma Manufacturing Delivers Strategic Value 7/28/2026

    Domestic pharmaceutical manufacturing strengthens supply chain resilience, simplifies distribution, speeds market response, and reduces risk by aligning production with key markets.